APA (7th ed.) Citation

BJ, B., SM, E., VM, C., R, J., NK, M., & WT, A. (2023). Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. Life (Basel, Switzerland), 13(8), . https://doi.org/10.3390/life13081752

Chicago Style (17th ed.) Citation

BJ, Burger, Epps SM, Cardenas VM, Jagana R, Meena NK, and Atchley WT. "Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study." Life (Basel, Switzerland) 13, no. 8 (2023). https://doi.org/10.3390/life13081752.

MLA (9th ed.) Citation

BJ, Burger, et al. "Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study." Life (Basel, Switzerland), vol. 13, no. 8, 2023, https://doi.org/10.3390/life13081752.